Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase III Trial Sorafenib-Pravastatin Versus Sorafenib Alone for the Palliative Treatment of Child-Pugh A Hepatocellular Carcinoma

NCT01075555 is registered in ClinicalTrials.gov with Federation Francophone de Cancerologie Digestive as lead sponsor.

NCT NCT01075555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01075555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase III Trial Sorafenib-Pravastatin Versus Sorafenib Alone for the Palliative Treatment of Child-Pugh A Hepatocellular Carcinoma
Lead sponsor
Federation Francophone de Cancerologie Digestive
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2010
Completion date
September 30, 2015
Enrollment
323 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer